Close Menu

NEW YORK (GenomeWeb) – The US Patent and Trademark Office has denied an attempt by Foundation Medicine to invalidate a patent held by Guardant Health.

In a decision issued June 5, the Patent Trial and Appeal Board denied Foundation Medicine's request to institute Inter Partes review for US Patent No. 9,598,731.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.